The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsHealth
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Released July 28, 2017
About This Episode
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Releas...
Podcast
This episode belongs to FDA Drug Information Updates.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 28, 2017, 00:06:00 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Information Updates.
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
May 4, 2018 - 00:02:59
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Jan 7, 2018 - 00:08:29
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
Jan 5, 2018 - 00:02:59
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Oct 29, 2017 - 00:09:22
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Aug 17, 2017 - 00:05:29
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Jul 25, 2017 - 00:09:00
Questions About This Episode
What is FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer about?
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Released July 28, 2017
Where can I listen to FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer?
You can listen to FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer from?
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer is an episode from FDA Drug Information Updates by ReachMD.
How long is this episode?
This episode is 00:06:00 long.
When was this episode published?
This episode was published on Jul 28, 2017.
Can I save FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Information Updates?
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer?
You can listen to FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer is from FDA Drug Information Updates by ReachMD.
What are the episode details?
Published Jul 28, 2017 and 00:06:00 long